Dosing of all patients in the trial has been successfully completedFinal results are expected to be available in late Q2 2024SAN DIEGO, April ...

Eli Lilly’s merestinib has seen its Phase Transition Success Rate (PTSR) drop after an investigator-led Phase II trial of the ...

New research suggests that GLP-1 drugs like Ozempic and Wegovy are not likely to increase the risk of thyroid cancer.

AstraZeneca AZN announced that the FDA has approved its marketed asthma drug, Fasenra (benralizumab), for use in children.

ASSESSING THE EFECTS OF MICRODOSING MB22001 IN MENSTRUATING PERSONS WITH AND WITHOUT PREMENSTRUAL SYNDROME AND PREMENSTRUAL DYSPHORIC DISORDER ...

Medivir AB (NASDAQ: MVIR) (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that an abstract for the ...

ENA Respiratory, a clinical-stage pharmaceutical company developing innate immune modulators for the prevention of ...

ARCH Venture Partners and Foresite Labs have invested $1 billion in AI-driven drug discovery firm Xaira Therapeutics, aiming ...

The expanded approval of FASENRA for use in younger patients comes after the regulator initially approved the therapy in 2017 ...

SNIPR Biome, a Copanhagen-based clinical-stage biotech company pioneering precision medicines using CRISPR technology for ...

Oral presentation of MDNA11’s Phase 1/2 ABILITY-1 Study will feature new and updated clinical dataUpdated bizaxofusp survival results from the ...

Peloton Drops Free Membership Option <li /> ARKO Arm Trumpets New Location <li /> Ocean Power Technology Loses Ground on News ...